Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study.
Marín-Jiménez I, Acosta MB, Esteve M, Castro-Laria L, García-López S, Ceballos D, Echarri A, Martín-Arranz MD, Busquets D, Llaó J, Navarro-Llavat M, Huguet JM, Argüelles-Arias F, Vicente R, Boudet JM, Díaz G, Sánchez-Migallón AM, Casellas F; for RAPIDA trial investigators.
Marín-Jiménez I, et al. Among authors: diaz g.
Gastroenterol Hepatol. 2022 Mar;45(3):165-176. doi: 10.1016/j.gastrohep.2021.04.010. Epub 2021 May 27.
Gastroenterol Hepatol. 2022.
PMID: 34051313
Clinical Trial.
English, Spanish.